Objective: Cannulation of the minor papilla (MiP) can be challenging. Historically, specialty accessories and small caliber guidewires have been advocated for approaching the MiP. New short-wire ERCP platforms allow physicians to control the guidewire, and have facilitated wire-guided ductal cannulation via the major papilla. The aim of this study is to describe the efficacy and safety of MiP cannulation using standard accessories and a wire-guided technique. Methods: All patients who underwent attempted MiP cannulation by 2 endoscopists (RA, JM) at 2 tertiary care medical centers between July 2005 and November 2008 were identified using institutional databases. These endoscopists exclusively employed the following cannulation technique. The MiP is identified, with or without the aid of secretin, and generally approached using a “long scope” position. Cannulation is attempted with a 4.4Fr tip sphincterotome loaded with a 0.035", 260cm guidewire. With the sphincterotome hovering in the duodenum, the physician-controlled guidewire is used to cannulate the orifice of the MiP, and then gently advanced 15-20 mm or until any resistance is met, using fluoroscopic guidance. The wire is secured and the sphincterotome advanced until it enters or abuts the MiP. Contrast is injected to delineate the dorsal duct anatomy. The wire is advanced more deeply into the dorsal duct and re-secured. The sphincterotome is passed deep into the dorsal duct. However, if the orifice doesn't permit passage of the sphincterotome, a needle knife is used to perform an access sphincterotomy alongside the guidewire. Electronic medical records were reviewed to assess for complications. Results: 24 patients were identified (14 women, mean age 46, 18 performed by RA). Procedure indications included recurrent acute pancreatitis in 17 patients (71%), idiopathic acute pancreatitis in 3 (13%), chronic pancreatitis in 1 (4%), and 3 patients had other indications. Pancreas divisum was suspected prior to the ERCP in 10 of 16 patients with prior imaging. Secretin was used in 9 patients (38%). MiP cannulation was successful in 23 patients (96%). Sphincterotomy followed by pancreatic stent placement (5-7 Fr) was performed in 20 patients (83%). The median procedure time (recorded in 18 patients) was 31 minutes. Complications occurred in 3 patients (13%), who developed mild post-ERCP pancreatitis. Conclusion: Physician-controlled wire-guided cannulation of the MiP using a 4.4Fr sphincterotome and 0.035" guidewire is an effective and safe technique that may obviate the need for specialty MiP accessories and small caliber guidewires. Further prospective evaluation of this technique is warranted.